Results 211 to 220 of about 535,239 (304)

Design and development of lipid nanoparticle formulations for brain gene therapy. [PDF]

Mol Ther Nucleic Acids
Thomson SB, de Moura Gomes A, Kazemian P, Kurek DZ, Kulkarni JA, Sadaati F, Wagner PK, Petkau TL, Ciufolini MA, Cullis PR, Leavitt BR.   +10 more
europepmc   +1 more source

Decreased Expression by a Chemically Modified siRNA to PTBP1 Seriously Affects Warburg Effect in Colorectal Cancer Cells. [PDF]

Cancer Sci
Matsumoto K, Hayashi H, Tokumaru Y, Fujibayashi S, Mitsui N, Endo M, Horaguchi T, Hatanaka Y, Yokoi R, Mizutani C, Kuno M, Fukada M, Asai R, Yasufuku I, Sato Y, Tajima JY, Tanaka Y, Nakashima R, Akao Y, Matsuhashi N.   +19 more
europepmc   +1 more source

Study on Synergistic Treatment of Pancreatic Cancer by Multiple Small Interfering Ribonucleic Acid Lipid Nanoparticles of Disk Domain Receptor 1, Transforming Growth Factor β1, Tumor-Associated Calcium Signal Transduction Protein 2, and Polyligand Proteoglycan 1. [PDF]

Pharmaceutics
Wang R, Zeng Y, Zeng Z, Xie T.
europepmc   +1 more source

Surface chemistry governs sex-dependent responses to PEG and zwitterionic siRNA nanocarriers in primary macrophages. [PDF]

Sci Adv
Lanier OL, Morse BA, Cisneros EP, Chapa-Villarreal FA, Maestas-Olguin A, Al Buzz R, Savk A, Peppas NA.   +7 more
europepmc   +1 more source

Target-Product and Translational Design Principles for Inhalable RNA Nanomedicines. [PDF]

Pharmaceutics
Omidian H, Dey Chowdhury S, Cubeddu LX.
europepmc   +1 more source

RICERCA E CREATIVITA' COME STILE DI VITA

, 2007
SIRNA, Concetta
core  

VRK3 promotes KSHV infection by suppressing the antiviral type I interferon response. [PDF]

PLoS Pathog
Yu CJ, Damania B.
europepmc   +1 more source

Per un dialogo interculturale

, 2009
SIRNA, Concetta
core   +1 more source

Fast activity prediction of chemically modified siRNAs via structure-based energy calculations and inference-augmented tabular deep learning. [PDF]

Mol Ther Nucleic Acids
Tan W, Dong Y, Shi Y, Chen N, Ye S, Zhang H, Chen P, Zuo Y, Du H.   +8 more
europepmc   +1 more source

RUNX1 upregulation and RUNX1-ETO depletion inhibits survival of t(8;21)-positive leukemia cells. [PDF]

Glob Med Genet
Zhang J, Sun R, Chen Y, Lu X, Zhang Q, Wang X, Jiang X, Liu Z, Li D, Yang G, Meng Y, Wang K, Yang S, Zhao X.   +13 more
europepmc   +1 more source